Verweise von und zu Lupus erythematosus systemic
Zurück zum ArtikelVerweise von anderen Artikeln
- Acute tubulointerstitial nephritis
- Age-associated B cells
- Ama
- Amicrobial intertriginous pustulose
- Anakinra
- Angiosarcoma of the head and face skin
- Anti-histone antibodies
- Antiphospholipid antibodies
- Apoptosis
- ATG5-gene
- Autophagy-gene
- BAFF
- BAFF receptor
- Barbiturates
- Belimumab
- Blys
- BTK inhibitors and autoimmun diseases
- Bullous systemic lupus erythematosus
- B cell activating factor
- B-cell regulatory
- B-cell receptor
- Complement Component 2 Deficiency
- Complement component 3 deficiency, autosomal recessive
- C4A Gene
- Complement component 5 deficiency
- Complement Component 8 Deficiency, Type 1
- Cathepsin
- Ccl13
- Ccp-ak
- CD19 CAR-T cells
- Chilblain lupus
- Chloroquine
- Ciclosporin a
- CR2 Gene
- Cxcl13
- Cyclophosphamide
- Intestinal diseases, skin changes
- Dermadrome
- Dermatitis-arthritis syndromes
- Dermatitis herpetiformis
- Juvenile dermatomyositis
- DNASE2 Gene
- Double-stranded dna antibodies
- Ena
- Endocarditis libman sacks
- Epigenetics
- Epigenetics
- Acquired haemophilia A;
- Erythrophobia
- Erythema perstans faciei
- Erythronychia
- Factor xii deficiency
- FASL gene
- FASLG Gene
- FCGR3A Gene
- FCN3 Gene
- Fat embolism
- Functional autoantibodiy
- Facial edema
- Gingivitis
- Goodpasture's syndrome
- Histones
- Hodgkin's lymphoma, skin manifestations
- Hydralazine disease
- Hydroa vacciniforme
- IFIH1 Gene
- Selective deficiency of immunoglobulin A
- Immunoadsorption
- PID autoinflammatory diseases
- PID
- PID - combined T/B/NK immundeficiency- SCID and CID
- PID - deficiency of complement
- Immune complexes
- Inflammasome
- Interface dermatitis
- Interferons
- Interferon regulatory factors
- Interleukin-10
- Interleukin-6
- Interleukin-9
- Granulomatous interstitial Dermatitis with arthritis
- IRAK1 Gene
- Ivig
- Cold agglutinins
- Calcium antagonists, side effects
- Iatrogenic Kaposi`s sarcoma
- Kikuchi fujimoto syndrome
- Kohlmeier Degos disease
- Complement factor I deficiency
- Complement system
- Cryoglobulins and skin
- La antibody
- Leflunomide
- Libman-sacks syndrome
- Swelling of the eyelids
- Linear IgA dermatosis
- Lung diseases, skin changes
- Lupus band test
- Lupus erythematosus acute-cutaneous
- Lupus erythematodes chronicus discoides
- Lupus erythematosus profundus
- Lupus erythematosus subacute-cutaneous
- Lupus erythematosus tumidus
- Lupus erythematosus visceralis
- MDA5
- Membranoproliferative glomerulonephritis
- Menstrual cycle, skin changes
- Minimal change glomerulopathy
- Mixed connective tissue disease
- Molecular mimikry
- Morbus Morbihan
- Cutaneous focal mucinosis
- Cutaneous mucinosis of infancy
- Multiple cutaneous focal mucinosis
- Mycophenolate mofetil
- Neonatal lupus erythematosus
- Neutropenia
- Renal diseases skin changes
- Nokardiosis
- Palisade neutrophilic and granulomatous dermatitis
- PDCD1 gene
- Plasmapheresis
- Polyarteritis, symptomatic
- Pseudo-sle syndrome
- Pterygium unguis ventralis
- Ptt
- Pyoderma gangraenosum
- RASGRP1 Gene
- RIME
- Retroperitoneal fibrosis
- Rheumatoid factors
- Rheumatoid arthritis and skin manifestations
- Rituximab
- Ro antibody
- Red lunulae
- Rowell's syndrome
- Vaccination and Induction of Autoimmune Diseases
- Schnitzler syndrome
- Scl-70 antibody
- Silicosis
- Singleton-merten syndrome
- Sle
- Smith antibody
- Sneddon syndrome
- Spondyloenchondrodysplasia
- Stat
- STAT4
- Subcorneal pustular dermatosis (Sneddon-Wilkinson)
- Sweet syndrome
- System erythematodes
- Teleangiectasia
- Teleangiectasia
- Thalidomide
- Thrombophilia, hereditary
- Platelet
- TLR5 gene
- Tocilizumab
- Toll-like receptor 3
- Toll-like receptor 7
- Toll-like receptor 9
- Trex1 gene
- Tripterygium Wilfordii HOOK.F. (TwHF)
- Type -I interferons
- U1-rnp antibody
- UNC93B1 GENE
- Urticaria vasculitis
- Vasculitis leukocytoclastic (non-iga-associated)
- Xeroderma pigmentosum
- ZAP70 tyrosinekinase
- Gluten-Related Dermatological Disorders
Verweise zu anderen Artikeln
- Alopecia (overview)
- Alopecia scarring
- Anakinra
- Antinuclear antibodies
- Antiphospholipid antibodies
- Antiphospholipid syndrome
- Apoptosis
- Drug-induced lupus erythematosus
- Atrophy of the skin (overview)
- Autoantibodies
- Autoimmune diseases
- Azathioprine
- BDCA-2
- Belimumab
- C1QA Gene
- C2 Gene
- C4 complement
- Chaperones
- Cheilitis
- Familial Chilblain Lupus
- Chloroquine
- Clasi
- C-reactive protein
- CTLA4
- Dermatomyositis (overview)
- DNASE1L3 Gene
- Double-stranded dna antibodies
- Effluvium
- Enanthem
- Erythema
- Gangrene
- Glomerulonephritides
- Glucocorticosteroids
- Granulocyte colony stimulating factor
- Scale
- Hydroxychloroquine
- Immunoadsorption
- Immunoglobulins
- Immune complexes
- Ivig
- Dilated cardiomyopathy
- Complement system
- Cryoglobulins and skin
- Leflunomide
- Libman-sacks syndrome
- Light protection
- Light stabilizers
- Livedo racemosa (overview)
- Livedovasculopathy
- Lupus band test
- Lupus erythematosus acute-cutaneous
- Lupus erythematodes chronicus discoides
- Cutaneous lupus erythematosus (overview)
- Lupus erythematosus systemic late-onset type
- Med
- Methylprednisolone
- Mixed connective tissue disease
- Mycophenolate mofetil
- Neonatal lupus erythematosus
- Nucleases
- Off-label use
- Plasmapheresis
- Plasmacytoid dendritic cell
- Polyarteritis nodosa systemic
- Prednisolone
- Prednisone
- Ptt
- Raynaud's syndrome
- Rheumatoid factors
- Rheumatic fever
- Rheumatoid arthritis and skin manifestations
- Serum disease
- Scleroderma systemic
- Smith antibody
- STING1-gene
- Sweet syndrome
- Syphilisserology
- Teleangiectasia
- TLR7 gene
- Tocilizumab
- Toll-like receptor 8
- Toll-like receptors
- Trex1 gene
- T-cell regulatory
- U1-rnp antibody
- Ulcer of the skin (overview)
- Adverse drug reactions of the skin
- Septic vasculitis